EUVIMEDEUVIMED entdecken
Crossref

Intranasal Delivery of si‐circHECTD1@mLNP for Cerebral Ischemic Stroke Therapy via Modulation of the Neuroinflammatory Microenvironment

Hui Ren, Ningbo Cai, Yan Sun, Guanlong Li, Zhuoyan Li, Ling Shen, Honghong Yao, Bing Han, Xinxin Huang, Yanpeng Jia iD

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.202600021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Hui Ren und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Jiangsu Provincial Key Laboratory of Critical Care Medicine, School of Medicine, Southeast University, Nanjing, Jiangsu, …. Hauptthemen laut MEDLINE: Ischemic Stroke, Ubiquitin-Protein Ligases, Nanoparticles, Neuroinflammatory Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Noncommunicable Chronic Diseases National Science and Technology Major Project, National Natural Science Foundation of China, Jiangsu Province Natural Science Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute ischemic stroke (AIS) is a leading cause of death and long‐term disability globally, with current treatment options offering limited efficacy in improving neurological recovery. Building upon our earlier discovery, we previously characterized circHECTD1, a circular RNA generated from exons 23–24 of the HECTD1 gene, as a critical regulator of ischemic brain injury. Despite its therapeutic potential, targeted interventions against circHECTD1 have yet to be developed. In this work, we report a mannose‐modified lipid nanoparticle for targeted delivery of si‐circHECTD1 ( si‐circHECTD1@mLNP ) to evaluate its therapeutic impact on neuroinflammation, infarct volume, and sensorimotor functions of stroke mice. In a murine transient middle cerebral artery occlusion (tMCAO) model, we found that nose‐to‐brain administration of si‐circHECTD1@mLNPs selectively inhibited circHECTD1 expression, subsequently alleviated neuroinflammation, suppressed both astrocytic and microglial activation, reduced infarct volume, and ultimately improved functional recovery. Transcriptomic profiling further demonstrates not only downregulation of neuroinflammation‐associated pathways but also upregulation of neuro‐restorative programs. Our findings confirm circHECTD1 as a pathogenic mediator and therapeutic target in AIS, while establishing a versatile mLNP platform for RNA therapy to improve neurological outcomes of AIS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ischemic StrokeUbiquitin-Protein LigasesNanoparticlesNeuroinflammatory DiseasesRNA, Small InterferingBrain IschemiaAnimalsMiceMaleAdministration, IntranasalMice, Inbred C57BLInfarction, Middle Cerebral ArteryDisease Models, AnimalMicroglia

Stichwörter der Autor:innen

RNA interferencedrug deliveryischemic strokelipid nanoparticlesmicroglianeuroinflammation

Substanzen

Ubiquitin-Protein LigasesRNA, Small Interfering

Autor:innen und Institutionen

  • Department of Pharmacology, Jiangsu Provincial Key Laboratory of Critical Care Medicine, School of Medicine, Southeast University, Nanjing, Jiangsu, China.
  • Co-innovation Center of Neuroregeneration, Nantong University, Nantong, China.
  • Institute of Life Sciences, Key Laboratory of Developmental Genes and Human Disease, Southeast University, Nanjing, China.
  • Center of Interventional Radiology & Vascular Surgery Department of Radiology, Medical School, Zhongda Hospital, Southeast University, Nanjing, China.

ORCID-Profile: Yanpeng Jia

Förderung

  • Noncommunicable Chronic Diseases National Science and Technology Major Project
  • National Natural Science Foundation of China
  • Jiangsu Province Natural Science Fund
  • Natural Science Foundation Outstanding Youth Fund of Jiangsu Province
  • Basic Research Program of Jiangsu
  • Fundamental Research Funds for the Central Universities
  • Nanjing U35 Strong Foundation Program

Zitieren

APA

Ren, H., Cai, N., Sun, Y., Li, G., Li, Z., Shen, L., Yao, H., Han, B., Huang, X., & Jia, Y. (2026). Intranasal Delivery of si‐circHECTD1@mLNP for Cerebral Ischemic Stroke Therapy via Modulation of the Neuroinflammatory Microenvironment. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202600021

Vancouver

Ren H, Cai N, Sun Y, Li G, Li Z, Shen L, et al. Intranasal Delivery of si‐circHECTD1@mLNP for Cerebral Ischemic Stroke Therapy via Modulation of the Neuroinflammatory Microenvironment. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202600021

BibTeX
@article{Ren2026,
  author = {Ren, Hui and Cai, Ningbo and Sun, Yan and Li, Guanlong and Li, Zhuoyan and Shen, Ling and Yao, Honghong and Han, Bing and Huang, Xinxin and Jia, Yanpeng},
  title = {Intranasal Delivery of si‐circHECTD1@mLNP for Cerebral Ischemic Stroke Therapy via Modulation of the Neuroinflammatory Microenvironment},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.202600021}
}
Kostenlos starten →